Atlas Trials

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

Clinical trial NCT00375310 · COMPLETED

Trial details

NCT number
NCT00375310
Sponsor
Indiana University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic CancerAdenocarcinoma of the Pancreas
Start date
2006-09-01
Primary completion
2010-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.